The primary goal of the Wisconsin Alzheimer's Disease Center (ADRC) Neuropathology and Biomarkers Core (Core D) is to facilitate the investigation of Alzheimer's disease (AD) and other dementias by University of Wisconsin (UW) investigators. The Core will accomplish this goal by providing complete and state-of-the- art characterization of disease pathogenesis and progression through biomarker, genetic and neuroimaging analysis, definitive neuropathologic diagnosis at autopsy and the preparation, banking and provision of frozen and fixed, non-demented control and AD brain tissues. In addition, the Core will enhance access to specialized proteomic and genomic technology to empower research progress. In particular, the Core will:
Specific Aim 1 : Perform rapid autopsies, obtain and archive representative frozen and fixed tissue blocks from multiple brain regions on deceased individuals who are enrolled in the Wisconsin ADRC as well as normal elderly controls, and generate NACC compatible diagnostic information.
Specific Aim 2 : Provide biomarker and genetic analyses in support of Wisconsin ADRC investigators and the procurement and management of tissues (blood, saliva, CSF).
Specific Aim 3 : Provide high quality, cost effective, cell and molecular neuroscience equipment, technology, assays, expertise, and training to Wisconsin ADRC investigators. This includes access to fluorescence and confocal microscopy, as well as specialized cell and molecular technology including Real Time PCR, DMA microarray analysis, 2-Dimensional gel electrophoresis, mass spectrometry, DMA and peptide synthesis and sequencing and metabolomics analysis.
Specific Aim 4 : Provide a service and infrastructure for AD-related brain imaging research. 4a) Advise investigators on protocols and analytic approaches;4b) Link the expertise of the vast brain imaging community at UW to the needs of Wisconsin ADRC investigators;4c) Collect a minimal standardized set of brain images on all ADRC participants at baseline;4d) Provide a location for investigators to store their images and analyze their data. In aggregate, these integrated services will greatly enhance basic and translational AD and dementia research on the UW-Madison campus.
An integrated set of core neuropathology, biomarkers and imaging services in this core will greatly empower ADRC researchers to implement transdisciplinary translational studies of AD. The core is organized to meet the needs of the ADRC as a whole and is oriented toward early detection of AD.
|Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064|
|Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10|
|Clark, Lindsay R; Koscik, Rebecca L; Allison, Samantha L et al. (2018) Hypertension and obesity moderate the relationship between ?-amyloid and cognitive decline in midlife. Alzheimers Dement :|
|Hadjichrysanthou, Christoforos; McRae-McKee, Kevin; Evans, Stephanie et al. (2018) Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies. J Alzheimers Dis 66:587-600|
|Hanfelt, John J; Peng, Limin; Goldstein, Felicia C et al. (2018) Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center. Neurobiol Dis 117:62-71|
|Martin, Stephen A; Souder, Dylan C; Miller, Karl N et al. (2018) GSK3? Regulates Brain Energy Metabolism. Cell Rep 23:1922-1931.e4|
|Swanson, Ashley; Wolf, Tovah; Sitzmann, Alli et al. (2018) Neuroinflammation in Alzheimer's disease: Pleiotropic roles for cytokines and neuronal pentraxins. Behav Brain Res 347:49-56|
|Gilmore-Bykovskyi, Andrea (2018) Commentary on Apathy as a Model for Investigating Behavioral and Psychological Symptoms in Dementia. J Am Geriatr Soc 66 Suppl 1:S13-S16|
|Burke, Shanna L; Hu, Tianyan; Fava, Nicole M et al. (2018) Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging :1-25|
|Johnson, Sterling C; Koscik, Rebecca L; Jonaitis, Erin M et al. (2018) The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directions. Alzheimers Dement (Amst) 10:130-142|
Showing the most recent 10 out of 374 publications